<VariationArchive RecordType="classified" VariationID="817114" VariationName="NM_005251.3(FOXC2):c.311_315del (p.Asp104fs)" VariationType="Deletion" Accession="VCV000817114" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2020-03-16" MostRecentSubmission="2020-03-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="805896" VariationID="817114">
      <GeneList>
        <Gene Symbol="FOXC2" FullName="forkhead box C2" GeneID="2303" HGNC_ID="HGNC:3801" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16q24.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="86566829" stop="86569728" display_start="86566829" display_stop="86569728" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="86600856" stop="86602538" display_start="86600856" display_stop="86602538" Strand="+" />
          </Location>
          <OMIM>602402</OMIM>
          <Haploinsufficiency last_evaluated="2013-11-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXC2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2013-11-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXC2">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="FOXC2-AS1" FullName="FOXC2 antisense RNA 1" GeneID="103752587" HGNC_ID="HGNC:50665" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16q24.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="86565145" stop="86567761" display_start="86565145" display_stop="86567761" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_005251.3(FOXC2):c.311_315del (p.Asp104fs)</Name>
      <CanonicalSPDI>NC_000016.10:86567645:ACCGC:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q24.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="86567646" stop="86567650" display_start="86567646" display_stop="86567650" variantLength="5" positionVCF="86567645" referenceAlleleVCF="GACCGC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="86601252" stop="86601256" display_start="86601252" display_stop="86601256" variantLength="5" positionVCF="86601251" referenceAlleleVCF="GACCGC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>D104fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.86567646_86567650del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.86567646_86567650del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.86601252_86601256del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.86601252_86601256del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012025.1" sequenceAccession="NG_012025" sequenceVersion="1" change="g.5396_5400del">
            <Expression>NG_012025.1:g.5396_5400del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012025.2" sequenceAccession="NG_012025" sequenceVersion="2" change="g.5818_5822del">
            <Expression>NG_012025.2:g.5818_5822del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_125795.1" sequenceAccession="NR_125795" sequenceVersion="1" change="n.112_116del">
            <Expression>NR_125795.1:n.112_116del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005251.3" sequenceAccession="NM_005251" sequenceVersion="3" change="c.311_315del" MANESelect="true">
            <Expression>NM_005251.3:c.311_315del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005242.1" sequenceAccession="NP_005242" sequenceVersion="1" change="p.Asp104fs">
            <Expression>NP_005242.1:p.Asp104fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1292" sequenceAccession="LRG_1292">
            <Expression>LRG_1292:g.5818_5822del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1292t1" sequenceAccession="LRG_1292t1">
            <Expression>LRG_1292t1:c.311_315del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1292p1" sequenceAccession="LRG_1292p1" change="p.Asp104fs">
            <Expression>LRG_1292p1:p.Asp104fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1597402505" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005251.3(FOXC2):c.311_315del (p.Asp104fs) AND not provided" Accession="RCV001008216" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-07-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-07-03" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-03-16" MostRecentSubmission="2020-03-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2305975" SubmissionDate="2019-10-15" DateLastUpdated="2020-03-16" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="GDX:2169607|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001167982" DateUpdated="2020-03-16" DateCreated="2020-03-16" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-07-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.311_315delACCGC variant in the FOXC2 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant causes a frameshift starting with codon Aspartic Acid 104, changes this amino acid to a Valine residue, and creates a premature Stop codon at position 357 of the new reading frame, denoted p.Asp104ValfsX357. This variant is predicted to cause loss of normal protein function through protein truncation, as the last 398 amino acids of the protein are lost and replaced with 356 incorrect amino acids. The c.311_315delACCGC variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.311_315delACCGC as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005251.2:c.311_315delACCGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6425168</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2305975" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

